Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer/version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a content system release without altering the study record details.SummaryDifference0.1%

- Check10 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to content or layout.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These are maintenance changes and do not affect the study content.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the page version updated from v3.4.0 to v3.4.1. There are no changes to the study details, outcomes, or core content presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.